Multivariate analyses of mometosome furoate versus fixed dose combination of salmeterol and fluticasone propionate in mild persistent asthma using an administrative claims database

被引:0
|
作者
McLaughlin, J.
Navaratnam, P. [1 ]
Urdaneta, E. [2 ]
Friedman, H. S.
机构
[1] Informagenics, Worthington, OH USA
[2] Analytic Solutions, New York, NY USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
157
引用
收藏
页码:S44 / S44
页数:1
相关论文
共 38 条
  • [1] The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma
    Condemi, JJ
    Goldstein, S
    Kalberg, C
    Yancey, S
    Emmett, A
    Rickard, K
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 82 (04) : 383 - 389
  • [2] Comparative long-term efficacy of ciclesonide versus a fixed combination of fluticasone propionate and salmeterol in mild persistent asthma
    Pedersen, S.
    O'Byrne, P.
    Postma, D.
    ALLERGY, 2007, 62 : 11 - 11
  • [3] An observational study of fixed dose combination fluticasone propionate/salmeterol or fluticasone propionate alone on asthma-related outcomes
    Stanford, Richard H.
    Fuhlbrigge, Anne
    Riedel, Aylin
    Rey, Gabriel Gomez
    Stempel, David A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (11) : 3141 - 3148
  • [4] Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma
    van Noord, JA
    Schreurs, AJM
    Mol, SJM
    Mulder, PGH
    THORAX, 1999, 54 (03) : 207 - 212
  • [5] Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma
    David I Bernstein
    Jacques Hébert
    Amarjit Cheema
    Kevin R Murphy
    Ivan Chérrez-Ojeda
    Carlos Eduardo Matiz-Bueno
    Wen-Ling Kuo
    Hendrik Nolte
    Allergy, Asthma & Clinical Immunology, 7
  • [6] Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma
    Bernstein, David I.
    Hebert, Jacques
    Cheema, Amarjit
    Murphy, Kevin R.
    Cherrez-Ojeda, Ivan
    Eduardo Matiz-Bueno, Carlos
    Kuo, Wen-Ling
    Nolte, Hendrik
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2011, 7
  • [7] Non-inferiority efficacy comparison of mometasone furoate/formoterol versus fluticasone propionate/salmeterol combination therapies in subjects with persistent asthma
    David I Bernstein
    Kevin R Murphy
    Hendrik Nolte
    Allergy, Asthma & Clinical Immunology, 6 (Suppl 2)
  • [8] A Multivariate Outcomes Analysis of Mometasone Furoate versus Fluticasone Propionate Outcomes in Mild Persistent Asthmatics with Prior Asthma Medication Use
    Navaratnam, P.
    Urdaneta, E.
    Friedman, H. S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S42 - S42
  • [9] Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs
    Delea, Thomas E.
    Stanford, Richard H.
    Hagiwara, May
    Stempel, David A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (12) : 3435 - 3442
  • [10] Efficacy and Safety of Fluticasone Furoate/Vilanterol Compared With Fluticasone Propionate/Salmeterol Combination in Adult and Adolescent Patients With Persistent Asthma A Randomized Trial
    Woodcock, Ashley
    Bleecker, Eugene R.
    Lotvall, Jan
    O'Byrne, Paul M.
    Bateman, Eric D.
    Medley, Hilary
    Ellsworth, Anna
    Jacques, Loretta
    Busse, William W.
    CHEST, 2013, 144 (04) : 1222 - 1229